President Donald Trump said last week he is working on an executive order that would require drug companies to charge the U.S. government lower prices, comparable to what some other countries pay. He dubbed it a “favored nations” clause, something often seen in trade agreements, where the seller agrees to give the buyer the best price it gives any customer. There are few details about the proposal. But the president raised an interesting question: Why do some other countries, like Canada and Germany, currently get a better deal on drug prices than the U.S., and what can be done about it?
Click the audio player to hear the full story.
If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air. But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.
Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.
When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.